On Tuesday, TD Ameritrade Holding Corp. (NYSE:AMTD)s shares declined -1.63% to $33.28.
TD Ameritrade Holding Corp. (AMTD) has 49.80% institutional ownership while its EPS ratio was 1.47. The company has 543.18 million shares outstanding while market capitalization of the company was $18.13 billion. Price to book ratio was 3.63. Net profit margin of the company was 31.70% while gross profit margin was 99.80%. Stock volatility for the month was booked as 2.44% while for the week was recorded as 2.41%.
TD Ameritrade Holding, has released results for fiscal 2015. The Company gathered about $63 billion in net new client assets, maintaining its industry-leading double-digit net new client asset growth rate for the seventh successive year.
The Company’s results for the fiscal year ended Sept. 30, 2015 comprise the following:
- Record $1.49 earnings per diluted share, on record net income of $813 million
- Record net new client assets of about $63 billion, an annualized growth rate of 10 percent
- Record average client trades per day of about 462,000, an activity rate of 7.1 percent
- Record net revenues of $3.2 billion, 55 percent of which were asset-based
- Record investment product fee revenue of $334 million, up 8 percent year-over-year
- Record pre-tax income of $1.3 billion, or 40 percent of net revenues
- Record EBITDA(2) of $1.5 billion, or 47 percent of net revenues
- Record interest rate-sensitive assets(3) of $108 billion, up 8 percent year-over-year
- Client assets of about $667 billion, up 2 percent year-over-year
TD Ameritrade Holding Corporation (TD Ameritrade) is an investment banking and a retail discount securities brokerage company. The parent company is Delaware Corporation. The Company provides securities brokerage services and related technology-based financial services to retail investors, traders and independent registered investment advisors (RIAs). The Company provides its services through the Internet, a national branch network and relationships with RIAs.
Aetna Inc (NYSE:AET)s shares gained 2.66% to $110.67.
Aetna Inc (AET) Its past 5-day performance at -1.81%. So far in 2015, the company has a year-to-date performance of 22.78%. The stock, as of last close, traded 46.69% up from its 52 week low and was -17.29% below its 52 week high. Its latest closing price was 0.98% above the SMA200 while the distance from SMA 50 and SMA 20 was -2.53% and 0.70% respectively.
Aetna, introduced a new suite of plans that give small employers with up to 100 employees additional, affordable health care options starting January 1, 2016.
The 16 different plan designs comprise indemnity, point-of-service and PPO options. All medical plans also comprise pediatric dental and vision benefits.
In addition to Aetna’s broad network of providers and facilities, the majority of plans comprise the Aetna Whole Health – Colorado Front Range network, a specially selected network of high-performing, high-quality local health care providers designed to deliver a coordinated patient experience while reducing costs.
The plans will be marketed and sold through agents and brokers across the state.
Aetna Inc. is a diversified health care benefits company. The Company offers a range of traditional, voluntary and consumer-directed health insurance products and related services. The Companys operations are conducted in three business segments: Health Care, Group Insurance and Large Case Pensions. The Companys Health Care segment includes medical, pharmacy benefit management services, dental, behavioral health and vision plans.
At the end of Tuesday’s trade, GlaxoSmithKline plc (ADR) (NYSE:GSK)s shares dipped -0.78% to $41.74.
GlaxoSmithKline plc (ADR) (GSK) has market capitalization of $101.76 billion. Its current ratio was 1.30 while its shares were above its 50 days simple moving average with 3.29%. The company offered earning per share of $6.14 while its 5.31 billion shares were outstanding. YTD performance of the company was -2.45%. Stock volatility for the week was 1.22% while for the month it was shown at 1.50%.
GlaxoSmithKline plc. (GSK) is a healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products. The Company operates in two segments: Pharmaceuticals and Vaccines, and Consumer Healthcare. The Pharmaceuticals segment develops and makes medicines to treat a range of acute and chronic diseases. Its human immunodeficiency virus (HIV) business is managed through ViiV Healthcare. GSKs Vaccines has a portfolio of over 30 paediatric, adolescent, adult travel vaccines.
This article is published by www.stocksnewswire.com. The content included in this article is just for informational purposes only. Stocksnewswire.com takes sensible consideration to ensure that the data given in this article is up to date and accurate. The news, prices, opinions, research, analysis, and other information published in this article are obtained from sources believed to be reliable.
Neither Stocksnewswire.com nor any of Stocksnewswire.com partners make any representation or guarantee as to the fulfillment or precision of the information contained in this article.
Investors must consult their own additional due diligence with any potential investment or highlighted company before making any decision on behalf of information offered by Stocksnewswire.com.
Information contained in this article may contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long-term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.